Work on new Oxford Haemophilia and Thrombosis Centre begins
28/01/2021
This article is more than three years old.
Oxford University Hospitals (OUH) has this week (25-29 January 2021) started work on a dedicated new centre to care for patients with bleeding and clotting disorders.
The Oxford Haemophilia and Thrombosis Centre (OHTC) will be located on the former Mayfair Ward at the Nuffield Orthopaedic Centre in Oxford.
The former Mayfair Ward, which has been vacant for some years, will be stripped out, modernised, and re-designed for the OHTC.
Completion is due at the end of 2021, and the overall budget is £4 million.
Currently based at the Churchill Hospital, the OHTC is the second largest comprehensive care centre in the UK, and is internationally renowned for its award-winning services and innovative research.
Speaking as work started, Dr Nicola Curry, Head of Department for the Oxford Haemophilia and Thrombosis Centre, said:
"We are hugely excited by this project as we have been given a largely blank canvas on which to design our new OHTC.
"The building is tucked away from the main hospital in its own calming green space, and has parking outside, so it is a perfect location for our patients.
"We are also delighted with our new layout as it combines efficient, light, and airy treatment areas for our patients, with co-located offices, labs, and staff rooms to make the most of the available space. We are really looking forward to moving in."
Sam Foster, Chief Nursing Officer at Oxford University Hospitals, said:
"The new Oxford Haemophilia and Thrombosis Centre will help us continue to deliver high-quality care to patients with bleeding and clotting disorders in an improved and more modern setting, so we are delighted that work on the project has started.
"In addition, staff are excited to move to their new 'home' at the Nuffield Orthopaedic Centre, where they will benefit from new areas to work and relax."
OHTC is dedicated to providing specialist care locally, regionally, and nationally to adults and their families diagnosed with Haemophilia A, Haemophilia B, Von Willebrands Disease, acquired haemophilia, and other rare forms of inherited bleeding disorders.
The team also provides holistic care to patients with thrombotic disorders and will continue to offer its award-winning one-stop DVT diagnostic service.
The overall aim of the OHTC service is to enable patients with haemophilia and other bleeding disorders, as well as patients with thrombotic disorders, to receive optimal treatment of their medical, physical, and psychosocial needs.